PMID: 6106725Sep 1, 1980Paper

Results of a clinical phenazepam study in the psychopathological changes in ischemic heart disease

Kardiologiia
V P ZaĭtsevA B Mukhanov

Abstract

Phenasepam was studied by the double blind method in comparison with seduxen according to the random principle in 90 males under 60 years of age suffering from ischemic heart disease with psychopathological changes. Phenasepam was given in daily doses of 1.5-4 mg for 3-4 weeks. The psychic condition became normal or considerably improved in 57.2% of patients treated with phenasepam, in 43.8% of those given placebo for phenasepam, and in 21.7% of patients treated with seduxen. Phenasepam caused the best effect in syndromes of pointless anxiety, depression, and cardiophobia. The side-effects (somnolence, listlessness, ataxia) were mild and transient. The authors conclude that it is expedient to use phenasepam in the treatment of psychopathological changes in patients with ischemic heart disease. Psychological factors influencing the therapeutic effect of drugs and its assessment are discussed.

Related Concepts

Related Feeds

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.

Ataxias (MDS)

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Ataxia

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Related Papers

Neurología, neurocirugía, psiquiatría
E Pastrana
Neuropsychiatric Disease and Treatment
Trevor R Norman, James S Olver
© 2021 Meta ULC. All rights reserved